Peter R. Clements

1.6k total citations
45 papers, 1.3k citations indexed

About

Peter R. Clements is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Peter R. Clements has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 19 papers in Physiology and 18 papers in Organic Chemistry. Recurrent topics in Peter R. Clements's work include Lysosomal Storage Disorders Research (18 papers), Carbohydrate Chemistry and Synthesis (15 papers) and Glycosylation and Glycoproteins Research (13 papers). Peter R. Clements is often cited by papers focused on Lysosomal Storage Disorders Research (18 papers), Carbohydrate Chemistry and Synthesis (15 papers) and Glycosylation and Glycoproteins Research (13 papers). Peter R. Clements collaborates with scholars based in Australia, United States and United Kingdom. Peter R. Clements's co-authors include John J. Hopwood, Doug A. Brooks, C. Phillip Morris, D S Anson, Julie Bielicki, Teresa Occhiodoro, Peter J. Wilson, Vivienne Muller, Hamish S. Scott and Sharon Byers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Peter R. Clements

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter R. Clements Australia 21 920 487 400 355 287 45 1.3k
Julie Bielicki Australia 18 688 0.7× 342 0.7× 334 0.8× 245 0.7× 243 0.8× 25 971
Gouri Yogalingam Australia 20 617 0.7× 448 0.9× 393 1.0× 176 0.5× 266 0.9× 33 1.2k
Amparo Chabás Spain 26 1.4k 1.5× 727 1.5× 435 1.1× 503 1.4× 690 2.4× 90 1.8k
Yoshiyuki Suzuki Japan 21 1.1k 1.2× 772 1.6× 287 0.7× 311 0.9× 259 0.9× 49 1.4k
Kazuko Sukegawa Japan 30 1.8k 2.0× 627 1.3× 934 2.3× 618 1.7× 329 1.1× 100 2.3k
G. T. N. Besley United Kingdom 26 904 1.0× 948 1.9× 196 0.5× 250 0.7× 210 0.7× 87 1.9k
Jane M. Quirk United States 23 2.0k 2.2× 784 1.6× 691 1.7× 618 1.7× 563 2.0× 31 2.5k
Laura Gort Spain 24 758 0.8× 629 1.3× 221 0.6× 275 0.8× 282 1.0× 67 1.3k
Clare Beesley United Kingdom 17 607 0.7× 288 0.6× 262 0.7× 240 0.7× 123 0.4× 29 980
M M Hermans Netherlands 19 773 0.8× 615 1.3× 119 0.3× 404 1.1× 98 0.3× 28 1.4k

Countries citing papers authored by Peter R. Clements

Since Specialization
Citations

This map shows the geographic impact of Peter R. Clements's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Clements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Clements more than expected).

Fields of papers citing papers by Peter R. Clements

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Clements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Clements. The network helps show where Peter R. Clements may publish in the future.

Co-authorship network of co-authors of Peter R. Clements

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Clements. A scholar is included among the top collaborators of Peter R. Clements based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Clements. Peter R. Clements is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strobel, Jörg, et al.. (2023). Molecular Mechanisms Provide a Landscape for Biomarker Selection for Schizophrenia and Schizoaffective Psychosis. International Journal of Molecular Sciences. 24(20). 15296–15296. 3 indexed citations
2.
Huang, Yichao, Peter R. Clements, & Robert A. Gibson. (2015). Robust measurement of vitamin A status in plasma and blood dried on paper. Prostaglandins Leukotrienes and Essential Fatty Acids. 102-103. 31–36. 14 indexed citations
3.
Pham, Duc‐Truc, et al.. (2010). Dansyl substituted poly(acrylate)s: Synthesis, host-guest complexation, and viscosity study at molecular and macroscopic levels. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 1 indexed citations
4.
McIntyre, Chantelle, Ainslie L.K. Derrick‐Roberts, Enzo Ranieri, et al.. (2008). Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA. Molecular Genetics and Metabolism. 93(4). 411–418. 31 indexed citations
5.
Anson, Donald S., Chantelle McIntyre, Belinda J. Thomas, et al.. (2007). Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA.. PubMed. 5(1). 1–1. 31 indexed citations
6.
Karageorgos, Litsa, Doug A. Brooks, A.C. Pollard, et al.. (2007). Mutational analysis of 105 mucopolysaccharidosis type VI patients. Human Mutation. 28(9). 897–903. 97 indexed citations
7.
Karageorgos, Litsa, Doug A. Brooks, Paul Harmatz, et al.. (2006). Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy. Molecular Genetics and Metabolism. 90(2). 164–170. 29 indexed citations
8.
Ramsay, Steven L., Peter J. Meikle, John J. Hopwood, & Peter R. Clements. (2005). Profiling oligosaccharidurias by electrospray tandem mass spectrometry: Quantifying reducing oligosaccharides. Analytical Biochemistry. 345(1). 30–46. 28 indexed citations
9.
Karageorgos, Litsa, Paul Harmatz, A.C. Pollard, et al.. (2004). Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy. Human Mutation. 23(3). 229–233. 33 indexed citations
10.
Yogalingam, Gouri, Xiaoling Guo, Vivienne Muller, et al.. (2004). Identification and molecular characterization of α-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy. Human Mutation. 24(3). 199–207. 39 indexed citations
11.
Hein, Leanne K., John J. Hopwood, Peter R. Clements, & Doug A. Brooks. (2003). The α-l-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1639(2). 95–103. 11 indexed citations
12.
Clements, Peter R.. (2002). Carbohydrate Bioengineering: Interdisciplinary Approaches. (Eds T.T. Teeri, B. Svensson, H. J. Gilbert, T. Feizi). Australian Journal of Chemistry. 55(2). 179–179. 1 indexed citations
14.
Bunge, Susanna, et al.. (1998). Genotype–phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1407(3). 249–256. 64 indexed citations
15.
Brooks, Doug A., G. S. Harper, G J Gibson, et al.. (1992). Hurler syndrome: A patient with abnormally high levels of α-l-iduronidase protein. Biochemical Medicine and Metabolic Biology. 47(3). 211–220. 19 indexed citations
16.
Scott, Hamish S., D S Anson, Paul V. Nelson, et al.. (1991). Human alpha-L-iduronidase: cDNA isolation and expression.. Proceedings of the National Academy of Sciences. 88(21). 9695–9699. 125 indexed citations
17.
Gibson, G J, G. T. P. Saccone, Doug A. Brooks, Peter R. Clements, & John J. Hopwood. (1987). Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values. Biochemical Journal. 248(3). 755–764. 65 indexed citations
18.
Clements, Peter R., Don J. Mahuran, & John J. Hopwood. (1983). Improved concanavalin a-sepharose elution by specific readsorption of glycoproteins. Journal of Chromatography A. 261. 77–82. 8 indexed citations
19.
Mahuran, Don J., et al.. (1983). A high recovery method for concentrating microgram quantities of protein from large volumes of solution. Analytical Biochemistry. 129(2). 513–516. 29 indexed citations
20.
Clements, Peter R., et al.. (1981). Adaptive Behavior Scale, Part Two: predictive efficiency of severity and frequency scores.. PubMed. 85(4). 433–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026